Brown Martin L, Riley Gerald F, Schussler Nicki, Etzioni Ruth
Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892-7344, USA.
Med Care. 2002 Aug;40(8 Suppl):IV-104-17. doi: 10.1097/00005650-200208001-00014.
Cancer-specific medical care costs are used by health service researchers, medical decision analysts, and health care policymakers. The SEER-Medicare database is a unique data resource that makes it possible to derive incidence- and prevalence-based estimates of cancer-related medical care costs by site and stage of disease, by treatment approach, and for age and gender strata for individuals older than 65 years.
This paper describes the cost-related data available in the SEER-Medicare database, and discusses techniques and methods that have been used to derive various cost estimates from these data. The limitations of SEER-Medicare data as a source of cost estimates are also discussed.
Examples of cost estimates for colorectal and breast cancer derived from SEER-Medicare are presented, including estimates of incidence-based cost (average cost per patient) by the initial, terminal, and continuing care phases of cancer treatment. Estimates of cancer-related treatment costs, costs by type of treatment, and long-term costs are presented, as are prevalence-based costs (aggregate Medicare and national expenditures) by cancer type.
癌症特异性医疗费用被卫生服务研究人员、医疗决策分析师和医疗保健政策制定者所使用。监测、流行病学和最终结果（SEER）-医疗保险数据库是一种独特的数据资源，它能够按疾病部位和阶段、治疗方法以及65岁以上个体的年龄和性别分层，得出基于发病率和患病率的癌症相关医疗费用估计值。
本文描述了SEER-医疗保险数据库中与费用相关的数据，并讨论了从这些数据中得出各种费用估计值所使用的技术和方法。还讨论了SEER-医疗保险数据作为费用估计来源的局限性。
给出了从SEER-医疗保险中得出的结直肠癌和乳腺癌费用估计值的示例，包括癌症治疗初始、终末期和持续护理阶段基于发病率的费用（每位患者的平均费用）估计值。列出了癌症相关治疗费用、按治疗类型划分的费用以及长期费用的估计值，以及按癌症类型划分的基于患病率的费用（医疗保险总支出和国家支出）。
Zotero 插件